PT - JOURNAL ARTICLE AU - Mimkes, Jürgen AU - Janssen, Rainer TI - Test-adjusted results of mortality for Covid-19 in Germany, USA, UK AID - 10.1101/2020.11.03.20225268 DP - 2020 Jan 01 TA - medRxiv PG - 2020.11.03.20225268 4099 - http://medrxiv.org/content/early/2020/11/04/2020.11.03.20225268.short 4100 - http://medrxiv.org/content/early/2020/11/04/2020.11.03.20225268.full AB - In a disease, where all infected persons show symptoms, it is reasonable to calculate mortality by case to fatality rate CFR. Deaths follow infections by a certain time lag. However, in the Covid-19 pandemic many infectious patients show no or hardly any symptoms. The reported infections and deaths do not run parallel, but diverge with the volume of tests.Our investigations for Germany, USA and UK indicate that deaths do not follow the number of infections, but the positive rate of tests, multiplied by a constant factor F and shifted by about two weeks. These test adjusted results of mortality allow for the estimation of the number of deaths of Covid-19 about two weeks ahead, even in a sharply rising state of the pandemic. This gives medical authorities two weeks of time to plan for resources.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:no IRBAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yessee References